XML 55 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Employee Equity-Based Compensation Expense
For The Years Ended December 31,
202320222021
Total stock-based compensation expense$9.9 $12.7 $9.1 
Income tax benefit related to stock-based compensation1.3 3.3 2.3 
Impact on cash flow due to taxes paid related to net share settlement of equity awards4.7 2.5 1.7 
Intrinsic value of options exercised, equity-based liabilities paid, and the fair value of restricted stock units vested14.7 9.5 3.7 
Summary of Status of Outstanding RSU Awards A summary of the status of outstanding restricted stock units as of December 31, 2023, and changes during the year, is presented below:
 Time VestedPerformance-based
 SharesWeighted
Average
Grant Date
Fair Value
SharesWeighted Average Grant Date Fair Value
Restricted stock units outstanding at December 31, 2022
429,465 $29.16 277,110 $29.64 
Granted216,379 37.66 196,453 40.47 
Vested(177,804)29.28 (211,944)22.24 
Forfeited (65,633)33.74 (36,515)35.43 
Restricted stock units outstanding at December 31, 2023
402,407 $32.97 225,104 $36.54 
Summary of Status of Outstanding Stock Option Awards and Changes During the Year A summary of the status of outstanding stock option awards as of December 31, 2023, and changes during the year, is presented below:
SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Life (Years)Aggregate Intrinsic Value
Outstanding options at December 31, 2022
294,124 $50.53 3.3$— 
Exercised— — 
Expired(8,442)50.73 
Outstanding and exercisable options at December 31, 2023
285,682 $50.53 2.3$—